 | • レポートコード：MRC2-11QY01693 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は注射薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（自己免疫疾患、ホルモン障害、希少疾患、腫瘍学）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別注射薬の競争状況、市場シェア ・世界の注射薬市場：種類別市場規模 2015年-2020年（生物製剤、小分子） ・世界の注射薬市場：種類別市場規模予測 2021年-2026年（生物製剤、小分子） ・世界の注射薬市場：用途別市場規模 2015年-2020年（自己免疫疾患、ホルモン障害、希少疾患、腫瘍学） ・世界の注射薬市場：用途別市場規模予測 2021年-2026年（自己免疫疾患、ホルモン障害、希少疾患、腫瘍学） ・北米の注射薬市場分析：米国、カナダ ・ヨーロッパの注射薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの注射薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の注射薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの注射薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、F. Hoffmann-La Roche、GlaxoSmithKline、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
Market Analysis and Insights: Global Injectable Drugs Market
The global Injectable Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Injectable Drugs Scope and Market Size
Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Injectable Drugs market is segmented into
Biologics
Small molecules
Segment by Application, the Injectable Drugs market is segmented into
Auto-immune diseases
Hormonal Disorders
Orphan Diseases
Oncology
Regional and Country-level Analysis
The Injectable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Injectable Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Injectable Drugs Market Share Analysis
Injectable Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Injectable Drugs business, the date to enter into the Injectable Drugs market, Injectable Drugs product introduction, recent developments, etc.
The major vendors covered:
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
…
1 Study Coverage
1.1 Injectable Drugs Product Introduction
1.2 Market Segments
1.3 Key Injectable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Injectable Drugs Market Size Growth Rate by Type
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by Application
1.5.1 Global Injectable Drugs Market Size Growth Rate by Application
1.5.2 Auto-immune diseases
1.5.3 Hormonal Disorders
1.5.4 Orphan Diseases
1.5.5 Oncology
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Injectable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Injectable Drugs Revenue 2015-2026
2.1.2 Global Injectable Drugs Sales 2015-2026
2.2 Global Injectable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Injectable Drugs Competitor Landscape by Players
3.1 Injectable Drugs Sales by Manufacturers
3.1.1 Injectable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Injectable Drugs Revenue by Manufacturers
3.2.1 Injectable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Injectable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Injectable Drugs Revenue in 2019
3.2.5 Global Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Injectable Drugs Price by Manufacturers
3.4 Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Injectable Drugs Market Size by Type (2015-2020)
4.1.1 Global Injectable Drugs Sales by Type (2015-2020)
4.1.2 Global Injectable Drugs Revenue by Type (2015-2020)
4.1.3 Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Injectable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Injectable Drugs Market Size by Application (2015-2020)
5.1.1 Global Injectable Drugs Sales by Application (2015-2020)
5.1.2 Global Injectable Drugs Revenue by Application (2015-2020)
5.1.3 Injectable Drugs Price by Application (2015-2020)
5.2 Injectable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Injectable Drugs by Country
6.1.1 North America Injectable Drugs Sales by Country
6.1.2 North America Injectable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Injectable Drugs Market Facts & Figures by Type
6.3 North America Injectable Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Injectable Drugs by Country
7.1.1 Europe Injectable Drugs Sales by Country
7.1.2 Europe Injectable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Injectable Drugs Market Facts & Figures by Type
7.3 Europe Injectable Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Injectable Drugs by Region
8.1.1 Asia Pacific Injectable Drugs Sales by Region
8.1.2 Asia Pacific Injectable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Injectable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Injectable Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Injectable Drugs by Country
9.1.1 Latin America Injectable Drugs Sales by Country
9.1.2 Latin America Injectable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Injectable Drugs Market Facts & Figures by Type
9.3 Central & South America Injectable Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Injectable Drugs by Country
10.1.1 Middle East and Africa Injectable Drugs Sales by Country
10.1.2 Middle East and Africa Injectable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Injectable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Injectable Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Injectable Drugs Products Offered
11.1.5 AbbVie Related Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Description and Business Overview
11.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche Injectable Drugs Products Offered
11.2.5 F. Hoffmann-La Roche Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Injectable Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Injectable Drugs Products Offered
11.4.5 Sanofi Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Injectable Drugs Products Offered
11.1.5 AbbVie Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Injectable Drugs Market Estimates and Projections by Region
12.1.1 Global Injectable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Injectable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Injectable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Injectable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Injectable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Injectable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Injectable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Injectable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Injectable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Injectable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Injectable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Injectable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Injectable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Injectable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Injectable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Injectable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Injectable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Injectable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Injectable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Injectable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Injectable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Injectable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Injectable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Injectable Drugs Market Segments
Table 2. Ranking of Global Top Injectable Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Injectable Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Biologics
Table 5. Major Manufacturers of Small molecules
Table 6. Global Injectable Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Injectable Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Injectable Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Injectable Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Injectable Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Injectable Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Injectable Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Injectable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Drugs as of 2019)
Table 15. Injectable Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Injectable Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Injectable Drugs Price (2015-2020) (USD/Unit)
Table 18. Injectable Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Injectable Drugs Product Type
Table 20. Date of International Manufacturers Enter into Injectable Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Injectable Drugs Sales Share by Type (2015-2020)
Table 24. Global Injectable Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Injectable Drugs Revenue Share by Type (2015-2020)
Table 26. Injectable Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Injectable Drugs Sales Share by Application (2015-2020)
Table 29. North America Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Injectable Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Injectable Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Injectable Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Injectable Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Injectable Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Injectable Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Injectable Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Injectable Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Injectable Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Injectable Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Injectable Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Injectable Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Injectable Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Injectable Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Injectable Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Injectable Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Injectable Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Injectable Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Injectable Drugs Sales Market Share by Application (2015-2020)
Table 69. AbbVie Corporation Information
Table 70. AbbVie Description and Major Businesses
Table 71. AbbVie Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. AbbVie Product
Table 73. AbbVie Recent Development
Table 74. F. Hoffmann-La Roche Corporation Information
Table 75. F. Hoffmann-La Roche Description and Major Businesses
Table 76. F. Hoffmann-La Roche Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. F. Hoffmann-La Roche Product
Table 78. F. Hoffmann-La Roche Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Global Injectable Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 90. Global Injectable Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Injectable Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Injectable Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 94. North America: Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 96. Europe: Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Injectable Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 98. Asia Pacific: Injectable Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 100. Latin America: Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Injectable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 102. Middle East and Africa: Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Injectable Drugs Players
Table 107. Injectable Drugs Customers List
Table 108. Injectable Drugs Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Drugs Product Picture
Figure 2. Global Injectable Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Biologics Product Picture
Figure 4. Small molecules Product Picture
Figure 5. Global Injectable Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Auto-immune diseases
Figure 7. Hormonal Disorders
Figure 8. Orphan Diseases
Figure 9. Oncology
Figure 10. Injectable Drugs Report Years Considered
Figure 11. Global Injectable Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Injectable Drugs Sales 2015-2026 (K Units)
Figure 13. Global Injectable Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Injectable Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Injectable Drugs Sales Market Share by Region in 2019
Figure 16. Global Injectable Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Injectable Drugs Revenue Market Share by Region in 2019
Figure 18. Global Injectable Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Injectable Drugs Revenue in 2019
Figure 20. Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Injectable Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Injectable Drugs Sales Market Share by Type in 2019
Figure 23. Global Injectable Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Injectable Drugs Revenue Market Share by Type in 2019
Figure 25. Global Injectable Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Injectable Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Injectable Drugs Sales Market Share by Application in 2019
Figure 28. Global Injectable Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Injectable Drugs Revenue Market Share by Application in 2019
Figure 30. North America Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Injectable Drugs Sales Market Share by Country in 2019
Figure 33. North America Injectable Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Injectable Drugs Market Share by Type in 2019
Figure 39. North America Injectable Drugs Market Share by Application in 2019
Figure 40. Europe Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Injectable Drugs Sales Market Share by Country in 2019
Figure 43. Europe Injectable Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Injectable Drugs Market Share by Type in 2019
Figure 55. Europe Injectable Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Injectable Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Injectable Drugs Revenue Market Share by Region in 2019
Figure 60. China Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Injectable Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Injectable Drugs Market Share by Application in 2019
Figure 84. Latin America Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Injectable Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Injectable Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Injectable Drugs Market Share by Type in 2019
Figure 95. Latin America Injectable Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Injectable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Injectable Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Injectable Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Injectable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Injectable Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Injectable Drugs Market Share by Application in 2019
Figure 108. North America Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Injectable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
無菌注射薬の世界市場（～2026年） Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body. Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalenc…- 病院用注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…
- 特殊注射用ジェネリック医薬品の世界市場（～2026年） Market Analysis and Insights: Global Specialty Injectable Generics Market The global Specialty Injectable Generics market size is projected to reach US$ 10240 million by 2026, from US$ 9378.7 million in 2020, at a CAGR of 8.4%% during 2021-2026. Global Specialty Injectable Generics Scope and Market …
- 注射可能ドラッグデリバリー製剤の世界市場（～2026年） Market Analysis and Insights: Global Injectable Drug Delivery Formulation Market The global Injectable Drug Delivery Formulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Injectable Drug Delivery Formulation Scop…
- 注射可能型ドラッグデリバリーの世界市場（～2026年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. North Amer…